Allakos Inc.
ALLKNASDAQHealthcare
$0.33
+$0.00(+0.22%)
Market Cap$29743071
P/E Ratio—
52W High$1.56
52W Low$0.22
Allakos Inc.（ALLK）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ALLK · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Gross Profit | ($0.01B) | ($0.01B) | ($0.01B) | ($0.00B) | ($0.00B) |
| Gross Margin %(computed) | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.07B | $0.14B | $0.27B | $0.20B | $0.11B |
| G&A Expenses | $0.04B | $0.05B | $0.06B | $0.08B | $0.05B |
| Total Operating Expenses | $0.11B | $0.19B | $0.32B | $0.27B | $0.16B |
| Operating Income | ($0.12B) | ($0.20B) | ($0.32B) | ($0.27B) | ($0.16B) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.12B) | ($0.19B) | ($0.32B) | ($0.27B) | ($0.15B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.12B) | ($0.19B) | ($0.32B) | ($0.27B) | ($0.15B) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.30 | $-2.14 | $-5.06 | $-5.01 | $-3.10 |
| Wtd Avg Shares | 0.09B | 0.09B | 0.06B | 0.05B | 0.05B |
| EBITDA | ($0.11B) | ($0.19B) | ($0.31B) | ($0.27B) | ($0.16B) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · B
深入了解Allakos Inc.
关于Allakos Inc.（ALLK）损益表
Allakos Inc.（ALLK）损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年，ALLK实现营收$0.00B，毛利润($0.01B)（毛利率—），净利润($0.12B)（净利率—）。
常见问题
ALLK · 4 问Allakos Inc.（ALLK）2024财年营收为$0.00B，同比down—%。
ALLK revenueALLK salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09